APA-viite

Op den Kamp, Y. J., de Ligt, M., Dautzenberg, B., Kornips, E., Esterline, R., Hesselink, M. K., . . . Schrauwen, P. (2021). Effects of the SGLT2 Inhibitor Dapagliflozin on Energy Metabolism in Patients With Type 2 Diabetes: A Randomized, Double-Blind Crossover Trial. Diabetes Care.

Chicago-tyylinen lähdeviittaus

Op den Kamp, Yvo J.M., et al. "Effects of the SGLT2 Inhibitor Dapagliflozin On Energy Metabolism in Patients With Type 2 Diabetes: A Randomized, Double-Blind Crossover Trial." Diabetes Care 2021.

MLA-viite

Op den Kamp, Yvo J.M., et al. "Effects of the SGLT2 Inhibitor Dapagliflozin On Energy Metabolism in Patients With Type 2 Diabetes: A Randomized, Double-Blind Crossover Trial." Diabetes Care 2021.

Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.